- BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver
- BioLife Solutions Reports First Quarter 2024 Financial Results
- BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
- BioLife Solutions Announces the Divestiture of its Stirling Freezer Business
- BioLife Solutions to Present at TD Cowen and Key Bank Investor Conferences
More ▼
Key statistics
On Friday, BioLife Solutions Inc (BJX1:STU) closed at 19.60, -12.50% below its 52-week high of 22.40, set on Jun 14, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 19.80 |
---|---|
High | 19.80 |
Low | 19.60 |
Bid | 19.60 |
Offer | 20.00 |
Previous close | 19.70 |
Average volume | 0.00 |
---|---|
Shares outstanding | 46.03m |
Free float | 44.44m |
P/E (TTM) | -- |
Market cap | 988.74m USD |
EPS (TTM) | -1.43 USD |
Data delayed at least 15 minutes, as of May 31 2024.
More ▼